advancing-precision Product Portfolio

Admera’s Portfolio employs state-of-the-art genomics
technology, allowing for rapid screening of multiple genes
in parallel. All results are delivered in an actionable report,
allowing physicians to provide personalized healthcare to
their patients, based on their unique and specific needs.

Admera’s Product Portfolio

PGxOne_Plus_Test_Portfolio_Logo Product Portfolio
PGxOne_Test_Photo Product Portfolio

PGxOne™ Plus is a comprehensive pharmacogenomics (PGx) test that includes over 60 genes and 200 variants

Oncology_Test_Portfolio_Logo Product Portfolio
Cardiovascular_Photo Product Portfolio

Admera Health’s Oncology Test Portfolio spans the continuum of patient care. Included tests for supportive care, blood based non-invasive cancer testing, and comprehensive tumor profiling

Cardiovascular_Test_Portfolio_Logo Product Portfolio
Oncology_Photo Product Portfolio

Admera Health’s unique Cardiovascular Test Portfolio includes a suite of tests to aid in risk assessment, diagnosis, and treatment decisions for a wide range of cardiovascular disease conditions

RxVision_logo_final Product Portfolio

Admera Health’s Clinical Decision Support System

  • Gain digital access to all patients’ PGxOne™ Plus results even without an EMR integration
  • Easily navigate test results with dynamic searches, including by medication, therapeutic area, and drug interactions
  • Securely and easily refer a patient’s report to another physician
db685702-daa6-4bd4-b3f0-b76e9dc5f552 Product Portfolio